-

NYSE American to Suspend Trading Immediately in Winc, Inc. (WBEV)

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced that the staff of NYSE Regulation has now determined to immediately suspend trading in the common shares of Winc, Inc. (the “Company”) — ticker symbol WBEV — from the Exchange.

On December 5, 2022, the NYSE American announced that it was commencing proceedings to delist the Company. The Company had the right to request a review of this determination by a Committee of the Board of Directors of the Exchange. On December 12, 2022, the Company confirmed that it will not exercise that right. Accordingly, the NYSE American will now suspend trading in the common shares and will file a delisting application with the Securities and Exchange Commission.

Contacts

Company Contact:
Investor Contact
invest@winc.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

Industry:

NYSE Regulation

Release Versions
English

Contacts

Company Contact:
Investor Contact
invest@winc.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

More News From NYSE Regulation

NYSE Group Consolidated Short Interest Report

NEW YORK--(BUSINESS WIRE)--NYSE today reported short interest as of the close of business on the settlement date of February 27, 2026. SETTLEMENT DATE EXCHANGE TOTAL CURRENT SHORT INTEREST TOTAL PREVIOUS SHORT INTEREST (Revised) NUMBER of SECURITIES with a SHORT POSITION NUMBER of SECURITIES with a POSITION >= 5,000 SHARES 02/27/2026 NYSE 16,947,364,681 16,735,266,868 2,872 2,619 02/27/2026 NYSE ARCA 2,323,474,800 2,314,632,970 2,560 1,792 02/27/2026 NYSE AMERICAN 892,896,103 928,802,671 309...

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Allurion Technologies, Inc. (the “Company”) from the NYSE. NYSE Regulation reached its decision to commence proceedings to delist the Company’s Securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s...

NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common stock of Vicarious Surgical Inc. (the “Company”) — ticker symbol RBOT — from the NYSE. Trading in the Company’s Class A common stock will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Class A common stock pursuant to Section 802.01B of the NYSE’s Listed Compan...
Back to Newsroom